Ohcanbohtosat - Geert‐Jan Creemers

Aiddostahte ozu
  1. 1
    Translocation of <i>BCR</i> to chromosome 9: A new cytogenetic variant detected by FISH in two Ph‐negative, <i>BCR</i>‐positive patients with chronic myeloid leukemia

    Translocation of <i>BCR</i> to chromosome 9: A new cytogenetic variant detected by FISH in two Ph‐negative, <i>BCR</i>‐positive patients with chronic myeloid leukemia Dahkki Anne Hagemeijer, Arjan Buijs, E.M.E. Smit, Bart Janssen, Geert‐Jan Creemers, D van der Plas, Gerard C. Grosveld

    Almmustuhtton 1993
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands

    Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands Dahkki Laura M. Legué, Nienke Bernards, Sophie L. Gerritse, Thijs R. van Oudheusden, Ignace H. J. T. de Hingh, Geert-Jan Creemers, Albert J. ten Tije, V.E.P.P. Lemmens

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Clinical management of women with metastatic breast cancer: a descriptive study according to age group

    Clinical management of women with metastatic breast cancer: a descriptive study according to age group Dahkki Klaartje Manders, Lonneke V. van de Poll‐Franse, Geert‐Jan Creemers, Gerard Vreugdenhil, Maurice J.C. van der Sangen, Grard A. P. Nieuwenhuijzen, Rudi M. H. Roumen, Adri C. Voogd

    Almmustuhtton 2006
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature

    Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature Dahkki Sabine Venderbosch, Johannes H.W. de Wilt, Steven Teerenstra, O. J. L. Loosveld, Aart van Bochove, Harm Sinnige, Geert-Jan Creemers, Margot Tesselaar, Linda Mol, Cornelis J.A. Punt, Miriam Koopman

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan

    A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan Dahkki Jessica M. van der Bol, Ron H.J. Mathijssen, Geert-Jan Creemers, André Planting, Walter J. Loos, Erik A.C. Wiemer, Lena E. Friberg, Jaap Verweij, Alex Sparreboom, Floris A. de Jong

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population‐based analysis

    The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population‐based analysis Dahkki Maikel J. A. M. Bakens, Lydia G. van der Geest, Magreet van Putten, Hanneke W.M. van Laarhoven, Geert‐Jan Creemers, Marc G. Besselink, V.E.P.P. Lemmens, Ignace H. J. T. de Hingh

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study

    Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study Dahkki Willemieke P.M. Dijksterhuis, Rob H.A. Verhoeven, Marije Slingerland, Nadia Haj Mohammad, Judith de Vos‐Geelen, Laurens V. Beerepoot, Theo van Voorthuizen, Geert‐Jan Creemers, Martijn G.H. van Oijen, Hanneke W.M. van Laarhoven

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases

    Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases Dahkki Koen P. Rovers, Checca Bakkers, Felice N. van Erning, Jacobus W. A. Burger, Simon W. Nienhuijs, Geert A. Simkens, Geert-Jan Creemers, Patrick Hemmer, Cornelis J.A. Punt, V.E.P.P. Lemmens, Pieter J. Tanis, Ignace H. J. T. de Hingh

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre

    Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer:... Dahkki M. Bontenbal, Geert‐Jan Creemers, Hans J. Braun, A C de Boer, J Janssen, Rieneke B. Leys, Jan B. Ruit, S.H. Goey, P.C. van der Velden, L.G.M. Kerkhofs, Kristel L. Schothorst, Paul Schmitz, Hansje J. Bokma, Jaap Verweij, Caroline Seynaeve

    Almmustuhtton 2005
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial

    Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial Dahkki Inge Henselmans, Hanneke W.M. van Laarhoven, Hanneke C.J.M. de Haes, Meltem Tokat, Ellen G. Engelhardt, Pomme E. A. van Maarschalkerweerd, Marleen Kunneman, Petronella B. Ottevanger, Serge E. Dohmen, Geert-Jan Creemers, Dirkje W. Sommeijer, Filip De Vos, Ellen M.A. Smets

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial

    Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial Dahkki Inge Henselmans, Hanneke W.M. van Laarhoven, Pomme E. A. van Maarschalkerweerd, Hanneke C.J.M. de Haes, Marcel G. W. Dijkgraaf, Dirkje W. Sommeijer, Petronella B. Ottevanger, Helle‐Brit Fiebrich, Serge E. Dohmen, Geert-Jan Creemers, Filip De Vos, Ellen M.A. Smets

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for <b> <i>UGT1A1*28</i> </b> Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study

    Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for <b> <i>UGT1A1*28</i> </b> Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study Dahkki Floris A. de Jong, Diederik F.S. Kehrer, Ron H.J. Mathijssen, Geert‐Jan Creemers, Peter de Bruijn, Ron H. N. van Schaik, André Planting, Ate van der Gaast, Ferry A.L.M. Eskens, J Janssen, Jan B. Ruit, Jaap Verweij, Alex Sparreboom, Maja J.A. de Jonge

    Almmustuhtton 2006
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progression As First-Line Chemotherapy in Patients with HER2+ Metastatic Breast Cancer: HERTAX Trial

    Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progre... Dahkki Paul Hamberg, Monique M.E.M. Bos, Hans J. Braun, Jacqueline M. Stouthard, Gert A. van Deijk, Frans Erdkamp, Iris N. van der Stelt-Frissen, M. Bontenbal, Geert-Jan Creemers, Johanneke E.A. Portielje, Hans Pruijt, O. J. L. Loosveld, Willem M. Smit, E.W. Muller, Paul Schmitz, Caroline Seynaeve, Jan G.M. Klijn

    Almmustuhtton 2011
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

    Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients Dahkki Sophie A. Kurk, Petra H.M. Peeters, Rebecca K. Stellato, Bram Dorresteijn, Pim de Jong, Marion Jourdan, Geert‐Jan Creemers, Frans Erdkamp, Felix de Jongh, Peter A. M. Kint, Lieke H. J. Simkens, Bea C. Tanis, Manuel L. R. Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis J.A. Punt, Miriam Koopman, Anne M. May

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies

    Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies Dahkki Niels A.D. Guchelaar, Bo Jan Noordman, Stijn L.W. Koolen, Bianca Mostert, Eva V. E. Madsen, Jacobus W. A. Burger, Alexandra R. M. Brandt‐Kerkhof, Geert-Jan Creemers, Ignace H. J. T. de Hingh, Misha Luyer, Sander Bins, Esther van Meerten, Sjoerd M. Lagarde, Cornelis Verhoef, Bas P. L. Wijnhoven, Ron H.J. Mathijssen

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients

    UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients Dahkki Emma C. Hulshof, Mirjam de With, Femke M. de Man, Geert-Jan Creemers, Birgit Deiman, Jesse J. Swen, Saskia Houterman, Stijn L.W. Koolen, Sander Bins, Anna M.J. Thijs, Marjan Laven, Anke M. Hövels, Saskia Luelmo, Danny Houtsma, Katerina Shulman, Howard L. McLeod, Ron H. N. van Schaik, Henk‐Jan Guchelaar, Ron H.J. Mathijssen, Hans Gelderblom, Maarten J. Deenen

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Experiences of patients with metastatic colorectal cancer participating in a supervised exercise intervention during chemotherapy

    Experiences of patients with metastatic colorectal cancer participating in a supervised exercise intervention during chemotherapy Dahkki Calvin G. Brouwer, Marieke R. ten Tusscher, Bente M. de Roos, Elske C. Gootjes, Tineke E. Buffart, Kathelijn S. Versteeg, Isa H. Mast, Mirte Mayke Streppel, Inge M. Werter, Anne M. May, Henk M.W. Verheul, Laurien M. Buffart, Jeanine Roodhart, Miriam L. Wumkes, Dirkje W. Sommeijer, Geert-Jan Creemers, Hans‐Martin Otten, Annette van Zweeden, Aart Beeker, Johan J. B. Janssen, Karen Bolhuis

    Almmustuhtton 2025
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Survival of Patients With Cancer With <i>DPYD</i> Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis

    Survival of Patients With Cancer With <i>DPYD</i> Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis Dahkki Jonathan E. Knikman, Tycho A. Wilting, Marta López‐Yurda, Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man, Didier Meulendijks, Peter Nieboer, Helga Droogendijk, Geert-Jan Creemers, Caroline Mandigers, Alexander L.T. Imholz, Ron H.J. Mathijssen, Johanneke E.A. Portielje, Liselot Valkenburg‐van Iersel, Annelie Vulink, Marlene H.W. van der Poel, Arnold Baars, Jesse J. Swen, Hans Gelderblom, Jan H.M. Schellens, Jos H. Beijnen, Henk‐Jan Guchelaar, Annemieke Cats

    Almmustuhtton 2023
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

    Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease Dahkki Christophe Fermé, Houchingue Eghbali, J.H. Meerwaldt, Chantal Rieux, Jacques Bosq, Françoise Berger, T. Girinsky, Pauline Brice, Mars B. van’t Veer, Jan Walewski, P Lederlin, Umberto Tirelli, Patrice Carde, Éric Van Den Neste, Emmanuel Gyan, M. Monconduit, Marine Diviné, John Raemaekers, Gilles Salles, Evert M. Noordijk, Geert-Jan Creemers, Jean Gabarre, Anton Hagenbeek, Oumédaly Reman, Michel Blanc, José Thomas, Brigitte Vié, Hanneke C. Kluin‐Nelemans, Fernando Viseu, Joke W. Baars, Philip Poortmans, Pieternella J. Lugtenburg, C. Carrié, J. Jaubert, M. Henry‐Amar

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2–Positive Esophageal Adenocarcinoma: TRAP Study

    Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2–Positive Esophagea... Dahkki Charlotte I. Stroes, Sandor Schokker, Aafke Creemers, Remco J. Molenaar, Maarten C.C.M. Hulshof, Stephanie O. van der Woude, Roel J. Bennink, Ron A. A. Mathôt, Kausilia K. Krishnadath, Cornelis J.A. Punt, Rob H.A. Verhoeven, Martijn G.H. van Oijen, Geert-Jan Creemers, Grard A. P. Nieuwenhuijzen, Maurice J.C. van der Sangen, Laurens V. Beerepoot, Joos Heisterkamp, Maartje Los, Marije Slingerland, Annemieke Cats, Geke A.P. Hospers, Maarten F. Bijlsma, Mark I. van Berge Henegouwen, Sybren L. Meijer, Hanneke W.M. van Laarhoven

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: